Skip to main content

Verve Therapeutics, Inc.

VERVDelisted Jul 25, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001840574

Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.

13F holders, Q3 2022

Institutional positions in Verve Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
124
+23 vs. Q2 2022
Shares held
60.7M
+15.1M (+33.2%) vs. Q2 2022
Total value
$2.08B
+$1.39B (+199.3%) vs. Q2 2022
New holders
44
55 more added
Sold out
21
16 more reduced

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 124 institutions
Q1 2021: 0 institutionsQ2 2021: 69 institutionsQ3 2021: 73 institutionsQ4 2021: 96 institutionsQ1 2022: 92 institutionsQ2 2022: 101 institutionsQ3 2022: 124 institutionsQ4 2022: 123 institutionsQ1 2023: 125 institutionsQ2 2023: 121 institutionsQ3 2023: 134 institutionsQ4 2023: 157 institutionsQ1 2024: 163 institutionsQ2 2024: 167 institutionsQ3 2024: 174 institutionsQ4 2024: 166 institutionsQ1 2025: 191 institutionsQ2 2025: 176 institutionsQ3 2025: 9 institutionsQ4 2025: 4 institutionsQ1 2026: 3 institutionsQ2 2026: 3 institutions
Value heldQ3 2022: $2.08B
Q1 2021: $0Q2 2021: $2.25BQ3 2021: $1.81BQ4 2021: $1.66BQ1 2022: $1.06BQ2 2022: $695.8MQ3 2022: $2.08BQ4 2022: $1.21BQ1 2023: $911.8MQ2 2023: $1.16BQ3 2023: $847.0MQ4 2023: $1.04BQ1 2024: $1.08BQ2 2024: $371.8MQ3 2024: $364.6MQ4 2024: $443.9MQ1 2025: $369.3MQ2 2025: $819.4MQ3 2025: $1.53MQ4 2025: $344.0KQ1 2026: $0Q2 2026: $0
Institutions holding VERV and their total value by quarter
QuarterHoldersValue
Q2 20263$0
Q1 20263$0
Q4 20254$344.0K
Q3 20259$1.53M
Q2 2025176$819.4M
Q1 2025191$369.3M
Q4 2024166$443.9M
Q3 2024174$364.6M
Q2 2024167$371.8M
Q1 2024163$1.08B
Q4 2023157$1.04B
Q3 2023134$847.0M
Q2 2023121$1.16B
Q1 2023125$911.8M
Q4 2022123$1.21B
Q3 2022124$2.08B
Q2 2022101$695.8M
Q1 202292$1.06B
Q4 202196$1.66B
Q3 202173$1.81B
Q2 202169$2.25B
Q1 20210$0

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q2 2022.

Institutions holding VERV in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
MPM Oncology Impact Management LP635,792$21.8M5.17%+635,792New
BVF Inc650,000$22.3M0.92%+650,000New
Nikko Asset Management Americas, Inc.775,697$24.4M0.31%+660,465+573.2%Added
Deerfield Management Company, L.P. (Series C)750,000$25.8M0.51%+750,000New
Deep Track Capital, LP775,000$26.6M1.32%+775,000New
Sumitomo Mitsui Trust Holdings, Inc.775,697$26.6M0.02%+660,465+573.2%Added
Geode Capital Management, LLC782,712$26.9M0.00%+315,492+67.5%Added
Novo Holdings A/S911,111$31.3M1.50%−15,989−1.7%Reduced
Wellington Management Group LLP1,010,708$34.7M0.01%−252,676−20.0%Reduced
Avidity Partners Management LP1,042,706$35.8M0.78%+1,042,706New
PFM Health Sciences, LP1,168,808$40.1M1.54%+323,622+38.3%Added
T. Rowe Price Investment Management, Inc.1,254,816$43.1M0.03%+1,254,816New
Baker Bros. Advisors LP1,416,530$48.7M0.32%00.0%Unchanged
Redmile Group, LLC1,505,126$51.7M2.01%−328,421−17.9%Reduced
Federated Hermes, Inc.1,749,737$60.1M0.18%+651,900+59.4%Added
JPMorgan Chase & Co1,918,490$65.9M0.01%+563,852+41.6%Added
ARCH Venture Management, LLC2,008,809$69.0M8.95%−500,000−19.9%Reduced
State Street Corp2,799,834$96.2M0.01%+2,194,551+362.6%Added
Casdin Capital, LLC3,178,167$109.2M7.20%+40,000+1.3%Added
BlackRock Inc.3,376,210$116.0M0.00%+792,139+30.7%Added
ARK Investment Management LLCSuperinvestorARK Invest3,393,859$116.6M0.81%+1,359,735+66.8%Added
Vanguard Group Inc3,658,812$125.7M0.00%+1,316,619+56.2%Added
FMR LLC7,482,350$257.0M0.03%+2,166,571+40.8%Added
Alphabet Inc.10,974,011$377.0M19.25%00.0%Unchanged
Millennium Management LLC0$00.00%−371,671−100.0%Sold out
Renaissance Technologies LLC0$00.00%−311,200−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−114,117−100.0%Sold out
EcoR1 Capital, LLC0$00.00%−98,593−100.0%Sold out
Ergoteles LLC0$00.00%−74,000−100.0%Sold out
Two Sigma Investments, LP0$00.00%−56,781−100.0%Sold out
Pinz Capital Management, LP0$00.00%−51,800−100.0%Sold out
Marshall Wace, LLP0$00.00%−50,499−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−45,000−100.0%Sold out
Squarepoint Ops LLC0$00.00%−40,417−100.0%Sold out
Jump Financial, LLC0$00.00%−37,700−100.0%Sold out
HRT Financial LP0$00.00%−36,541−100.0%Sold out
1623 Capital LLC0$00.00%−26,999−100.0%Sold out
Gsa Capital Partners LLP0$00.00%−25,544−100.0%Sold out
HighTower Advisors, LLC0$00.00%−12,000−100.0%Sold out
Quantbot Technologies LP0$00.00%−6,500−100.0%Sold out
Simplex Trading, LLC0$00.00%−173−100.0%Sold out
State of Wyoming0$00.00%−121−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−23−100.0%Sold out
Captrust Financial Advisors0$00.00%−4−100.0%Sold out
Steward Financial Group LLC0$00.00%−2−100.0%Sold out